Hepatitis B virus (HBV) is one of the major causes of liver disease worldwide, and chronic HBV infection may progress to cirrhosis and hepatocellular carcinoma. Mutations at the active site of DNA polymerase of HBV, tyrosine-methionineaspartate-aspartate (YMDD) motif, render infected patients resistant to antiviral drug (Lamivudine) therapy. Hence, sensitive and specific methods aimed at detecting the mutants are essential. The purpose of this study was to develop methods for detecting the mutations at YMDD by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and real-time PCR using locked nucleic acid (LNA)-mediated TaqMan probes. The results obtained by these methods were compared with those examined by conventional direct sequencing on serum samples of 77 patients treated with lamivudine. Our results show that both PCR-RFLP and real-time PCR could detect wild type, YMDD, and its mutants, tyrosine-isoleucine-aspartate-aspartate and tyrosine-valineaspartate-aspartate. In addition, the mixtures of the wild-type virus and its mutants in the serum sample were detected. Importantly, real-time PCR is less time-consuming, and more sensitive for the detection of mixed populations than PCR-RFLP. The real-time PCR with LNA-mediated TaqMan probes is a sensitive, specific and rapid detection method for mutations at the YMDD motif, which will be essential for monitoring patients undergoing lamivudine antiviral therapy.
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Hepatitis B virus (HBV) is one of the major causes of liver disease worldwide, and chronic HBV infection can progress to cirrhosis and hepatocellular carcinoma (Jang et al. 2004) . It is estimated that 350 million individuals are chronically infected with HBV and that 1 to 2% will die each year as a consequence of infection related complications (Allen et al. 1999) . HBV is a member of the Hepadnaviridae, and has a relaxed-circular, partially double stranded DNA genome of approximately 3200 nucleotides. HBV replication occurs via reverse transcription using its own RNA-dependent DNA polymerase (Seeger and Mason 2000) . Many current therapeutic approaches for treating HBV infection focus on the DNA polymerase as a target to inhibit viral replication, including nucleoside analogs that terminate viral DNA synthesis (Allen et al. 1999) . One of the widely used nucleotide analogs, lamivudine, (-)-b-L-2′, 3′-dideoxy-3′-thiacytidine, has shown clinical benefits such as reduction of viral load and suppression of progression towards liver disease (Das et al. 2001; Papatheodoridis et al. 2002) . Lamivudine can be used as an alternative therapy, particularly in patients with resistance to interferon treatment (Terui et al. 2000) or preventing post-operative re-infection in liver transplant for acute fulminant hepatitis B patient (Inoue et al. 2005 ). However, long-term mono-therapy with lamivudine commonly does not result in complete suppression of viral replication and is associated with the emergence of resistant mutants (Cane et al. 1999) in the tyrosine-methionine-aspartate-aspartate (YMDD) motif of the polymerase gene (Pei et al. 2005) .
Mutations in the YMDD motif of HBV affect lamivudine treatment in HBV infected patients. Therefore, a rapid and accurate detection method to identify these mutants is crucial. Currently, the detection of lamivudine resistance HBV mutation is mainly accomplished by direct sequencing (Allen et al. 1998; Sablon and Shapiro 2005) . However, this method is time consuming and cannot simultaneously detect mixed populations of wild type and its mutant variant in a single-step reaction. Thus, it is not appropriate for routine clinical settings. Several other techniques such as polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) (Allen et al. 1999; Jardi et al. 1999; Sablon and Shapiro 2005) , line probe assay (Stuyver et al. 2000; Aberle et al. 2001 ), 5′nuclease assay (Allen et al. 1999) , and real-time PCR by using fluorescent resonant energy transfer (FRET) as a probe (Cane et al. 1999) , have been described for the detection of variants, each with its own advantages and disadvantages.
In the present study, two different methods to detect YMDD motif mutations were evaluated and compared with conventional direct sequencing: PCR-RFLP and real-time PCR by using locked nucleic acid (LNA)-mediated TaqMan probe, which is a nucleic acid analogue containing LNA nucleotide monomers with a bicyclic furanose unit locked in an RNA mimicking sugar conformation (Koshkin et al. 1998; Ichikawa et al. 1999; Wang et al. 1999) . LNA oligonucleotides display unprecedented hybridization affinity toward complementary double-stranded DNA. LNA increases the thermal stability (melting temperature) of oligonucleotides. This can be used to increase the sensitivity and specificity, thereby simultaneously detecting YMDD and its mutants, tyrosine-isoleucine-aspartate-aspartate (YIDD) and tyrosine-valine-aspartate-aspartate (YVDD) in a single multiplex reaction.
MATERIALS AND METHODS

Clinical samples
Seventy-seven serum samples investigated in this study were obtained from 77 patients with chronic HBV infection, who had attended the liver clinic, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, and had received lamivudine therapy for at least 6 months. All specimens were stored at −70°C until tested, and were used for comparisons between the various test results. The study was performed after approved by the University Ethics Committee, and written consent was obtained from all patients.
HBV DNA extraction
HBV DNA was extracted from 100 μ l of serum incubated with Proteinase K in lysis buffer, followed by phenol/chloroform extraction and ethanol precipitation. Finally, the pellet was dissolved in 30 μ l sterile water and stored at −20°C until further tested.
HBV DNA detection
The isolated HBV DNA was amplified by PCR using forward primer F1 (nt. 685-704: 5′-GCCATTTGTT CAGTGGTTCG-3′) and reverse primer R1 (nt.1015-995: 5′-AGCCCAAAAGACCCACAATTC-3′). The numbering of nucleotide sequences referred from HPBADW1 (D00329). The primers were designed to amplify the particular sequence coding for the YMDD motif of the viral polymerase. The amplification reaction was performed in a Mastercycler personal (Eppendorf, Humburg, Germany) applying the following conditions: 35 cycles at 94°C for 30 sec, 55°C for 30 sec and 72°C for 60 sec, followed by a final extension step at 72°C for 7 min. After electrophoresis in a 2% agarose gel stained with ethidium bromide on preparation, the expected 331-bp product was visualized on a UV trans-illuminator (BIO-RAD, Hercules, CA, USA).
PCR-RFLP analysis for mutation detection
HBV DNA was amplified by nested PCR, using F2 primer (nucleotide sequences fused with two parts of HBV nt. 716 -738 and Arabidopsis sp. nt.1638 -1658 for product elongation to easily visualize the clustered product): 5′-TTTGACTTAGGGCTTCATCACACTGTTTG GCTTTCAGTCAT-3′ and R2 (Combined with HBV nt. 928 -908 and Arabidopsis sp nt. 1913 -1896): 5′-TATAT TGATAACATGCACGTACAATATGTTCCT-3′) which induced mutagenesis in the amplified viral DNA. Two μ l of DNA template were added to the reaction mixture containing 12 μ l of 2.5X Eppendorf MasterMix (Eppendorf), 1 μ M F2 and R2 and sterile water to a final volume of 25 μ l. The PCR conditions were 35 cycles at 94°C for 30 sec, 55°C for 30 sec and 72°C for 60 sec, concluded by a final extension step at 72°C for 7 min. For the second round nested primers F3 (Arabidopsis sp. nt.1638-1658): 5′-TTTGACGTTAGGGCTTCATCA-3′ and R3 (HBV nt. 928 -908): 5′-GTACAATATGTTCCT GCGGTA-3′) were used as forward and reverse primer, respectively. Both reaction mixture and PCR conditions were identical to those in the first round except for using 0.5 μ l of the first round PCR product as the template for the second round amplification. Subsequently, the second round PCR products were subjected to RFLP analysis, using restriction endonucleases NdeI and NlaIII (New England Biolabs, Ipswich, MA, USA) to detect potential YMDD motif mutations at 37°C for 3 hrs in separate reactions. The resulting DNA fragments were determined by 3% agarose gel electrophoresis. The RFLP result became visible under UV light after staining with ethidium bromide.
HBV DNA direct sequencing
The PCR products amplified by primers F1 and R1 were purified from the gel using a commercially available Gel Extraction Kit (Eppendorf). The sequencing reaction was performed by using the Gene Amp PCR System 9600 (Perkin-Elmer, Boston, MA, USA) subjecting the resulting PCR products to a Perkin Elmer 310 Sequencer (Perkin-Elmer). The resulting HBV sequences were analyzed with the BLAST (http://www.ncbi.nlm. gov/BLAST) program and the respective mutation in the YMDD motif of each sample was determined using CLUSTAL X (Version 1.81 from ftp://ftp-igbmc. u-strasbg.fr/pub/ClustalX).
Plasmid construction for positive control
To obtain the HBV DNA standard for the three variants in the YMDD motif, YMDD, YIDD and YVDD, PCR using primers F1 and R1 was performed in separate reactions. The PCR products were separated by 2% agarose gel electrophoresis and purified using the Gel Extraction Kit (Eppendorf). These purified products were inserted into the pGEM-T Easy Vector System (Promega, Madison, WI, USA) according to the manufacturer's specifications. The resulting three variants of standard control plasmid were confirmed by direct sequencing (CUM: DQ351994; CUI: DQ351989; CUV: DQ352026).
Quantification of HBV DNA and LNA mediated TaqMan probe analysis
The samples previously identified as YMDD, YIDD, and YVDD served as controls for mutation detection based on real-time PCR with LNA mediated TaqMan probe analysis. The region spanning nucleotides 685 to 1015 of each wild type and two mutation strains was inserted into pGEM-T Easy Vector by T-A cloning. The recombinant plasmid concentrations were determined by measuring OD 260 and verified by agarose gel electrophoresis, PCR-RFLP and direct sequencing (data not shown). Ten-fold dilutions of the recombinant plasmid (10-10 10 copies/μ l) were detected by real-time PCR and used as a standard curve for HBV DNA quantification, performed by using F1 and R1 as the amplifying primers in the Rotor-Gene 3000 (Corbett Research, New South Wales, Australia). The reaction contained 1 μ l of DNA sample and a reaction mixture of Biotools QuantiMix KIT (Biotools, Madrid, Spain) comprising 2 μ l of QuantiMix Buffer A, 4 mM MgCl 2 , 0.2 mM dNTPs, 0.5 μ M F1, 0.5 μ M R1, 2 μ l of 1X SYBR Green, 1U DNA Polymerase and QuantiMix Buffer B in a final volume of 20 μ l. The real-time PCR conditions for quantification of HBV DNA were initially 10 min with hot start Taq DNA polymerase at 95°C followed by 35 cycles at 95°C for 15 sec, 55°C for 15 sec and 72°C for 30 sec. The fluorescent signal was detected once per cycle upon completion of the extension step.
For designing the LNA mediated TaqMan probes the following guidelines were applied: i) selection of the DNA strand harboring less G residues hence, the antisense strand, ii) for single mutation detection, Tm should differ by 7°C (Tm of the probes is approximately 67°C since primers F4 (nt. 697 -715: 5′-GTGGTTCGTAGGG CTTTCC-3′) and R4 (nt. 780 -760: 5′-AAGATGTTGTA CAGACTTGGC-3′) with Tm at approximately 60°C were used, iii) the mutation position should be an LNA base located centrally in the probe and iv) for genotypes A, B, C, D, E, and G to be detectable, nt.731 of these probes was used as the degenerated nucleotide (R: A or G). Accordingly, three types of LNA mediated TaqMan The conditions for the LNA mediated TaqMan probe assay were initially 10 min with hot start Taq DNA polymerase at 95°C followed by 45 cycles at 95°C for 15 sec and 66°C for 20 sec. Of each cycle at the extension step, the fluorescent signals of Probe YMDD, Probe YVDD and Probe YIDD were measured at 520, 550 and 650 nm, respectively.
Specificity and sensitivity testing
Ten-fold dilutions of the recombinant plasmid (10-10 10 copies/μ l) were used to establish the test's sensitivity. In the PCR-RFLP study, nested primers were used with the plasmids as templates and the results were obtained from 2% agarose gel electrophoresis. The lowest template concentration amplified represents the method's sensitivity. Likewise, real-time PCR with LNA mediated TaqMan probe was performed under identical conditions as described above except for using the recombinant plasmid as the template. Also, the lowest signals detectable represent the sensitivity of this method.
To determine the specificity of real-time PCR using LNA mediated TaqMan probe, each recombinant plasmid template and each probe were paired in separate reactions, e.g., template YMDD with Probe YMDD, probe YIDD or probe YVDD. Signals showing but not matching the respective template/probe pair, represent either non-specific reactions or cross reactions between probes and templates. Yet, if the signal only appears when probe and template match, it ensures the probe is specific for its template.
Data analysis
All samples were typed blindly to each variant by RFLP, sequencing and real-time PCR without any conscious bias. The results determined by different methods were also compared. The results of direct sequencing were used as the standard for comparison with the other methods. To confirm the PCR-RFLP and the real-time PCR data, the test was repeated on all specimens and yielded identical results.
RESULT
Direct sequencing and PCR-RFLP
Based on direct sequencing, 31 samples were classified as YMDD variant, 4 as YIDD mutant and 13 as YVDD mutant (Table 1) . However, 29 samples could not be sequenced, as the viral loads were below the threshold to be amplified by PCR (ND in Table 1 ). Using the extra long primer for PCR-RFLP analysis, the mixture containing wild type (YMDD) and mutant viruses (YIDD and YVDD) were detected (Fig. 1) . Since the nucleotide sequence for YMDD motif was devoid of restriction sites, base changes were introduced to create the NdeI and NlaIII restriction sites in the wild type and YVDD variant, respectively as described by Allen et al. (1999) . The primers (F2 and R2) used for mutagenesis played two distinct roles. Firstly, the restriction sites were created by the HBV complementary part at the forward primer and used to initiate the polymerase reaction. Secondly, due to the HBV non-complementary part, the PCR-RFLP results were clearly distinguishable after 3%-agarose gel electrophoresis: a 209-bp digested fragment versus a 248 bp nondigested product upon exposure to NdeI and a 191-bp digested fragment versus a 232-bp nondigested product upon exposure to NlaIII, respectively. However, with the recombinant plasmid as template, the sensitivity of this primer pair was 10 4 copies/μ l. This problem was solved by nest- ed-PCR for which another set of primers was designed: a forward primer (F3) complementary to the HBV non-complementary part of the F2 primer and a reverse primer (R3) complementary to the HBV complementary part of the R2 primer. This set of nested primers yielded two very interesting results. Firstly, the sensitivity was increased to 10 3 copies/μ l. Secondly, due to their higher specificity only the first round PCR products were amplified. Several times, this method was applied to analyze the sample of a patient infected with HBV and treated with lamivudine. Of 77 samples analyzed, 28 could not be amplified by PCR, 15 could not be classified, 13 were classified as wild type YMDD, 2 as YIDD mutant, 2 as YVDD mutant, 11 as mixed populations of YMDD and YIDD mutant, 5 as mixed populations of YMDD and YVDD, and 1 as mixed populations of YIDD and YVDD (Table 1) .
HBV DNA Quantification by Real-Time PCR
Ten fold dilutions of recombinant plasmid (10 9 to 10 copies/μ l) were detected using SYBR Green I by real-time PCR (Fig. 2A) . The standard curve was obtained by plotting cycle threshold (Ct) values, derived from fluorescence amplification plots, against the known copy number of each standard sample (Fig. 2B) . HBV DNA of all unknown samples was quantified by measuring the Ct value based on the standard curve. The results of both unknown and standard samples were reported and confirmed reproducible (Table  1) .
LNA Probe for real-time PCR
The results were analyzed based on the fluorescent channels. If the signals, depicted by the sigmoidal curve, appeared at the FAM channel, it indicated that the sample has the wild type YMDD motif. Moreover, in case of YIDD or YVDD the signals became visible at the Cy5 or Hex channel, respectively. Cross reaction tests were used to ensure that the probes specifically bind to the target. The result showed that only the matching between of the template and probe was given the signal, suggesting that there is not cross reaction in all three probes (Fig. 3) . Although, it was not verified on a true well characterized (as to presence of eventual mixtures) patient sample, it was not show the cross react on the other site of the HBV DNA in every genotype by the multiple alignment (data not shown). Moreover, the sensitivity of this method was 10 1 copies/μ l (data not shown). In an experiment aimed at detecting mixed populations, recombinant plasmids of the wild type (YMDD) and two mutants (YIDD and YVDD) were used as the template and the three probes were added in a single reaction. The result showed that this method could detect three types of the YMDD motif in a single reaction (Fig. 4) . Of the 77 samples, 5 were classified as wild type YMDD, 5 as YIDD mutant, 27 as YVDD mutant, (Table 1) .
DISCUSSION
Chronic HBV can be treated with a nucleoside analogue, lamivudine, which in the short term can inhibit HBV replication by blocking the viral polymerase activity. However, during longterm treatment, lamivudine resistant strains have been detected. Based on a previous study, this resistance has been associated with variations in the YMDD motif of the HBV polymerase which is the catalytic site (Bowden et al. 2003) . Resistance is found with either the YIDD or the YVDD mutant where the amino acid at the M position of the wild type has been changed to either I or V, respectively. The mutation in this region renders patient treatment ineffective. Therefore, it is an important to establish a method to detect these mutations as early as possible when the mutant virus is still minor fraction in the total HBV population. A previous study has shown several methods suitable to detect mutations in this region. Direct sequencing serves as the conventional method in that the nucleotide sequences are altered from ATG at codon 550 of the wild type to ATA and GTG in the YIDD and YVDD mutants, respectively (Genotype B and C) (Stuyver et al. 2001) . However, this conventional method can detect only major HBV populations but can not detect mixed populations as for example, YMDD and YIDD or YMDD and YVDD (Hong et al. 2004 ). This problem could be solved by applying more specific and sensitive methods (Kirishima et al. 2002) .
In this study, two methods for detection of the YMDD motif in the HBV polymerase were developed and evaluated in comparison with direct sequencing. First, a PCR-RFLP using extra-long primers was performed. The experiment showed that mixed populations between wild type and mutant (YMDD with YIDD or YVDD) or between mutant and mutant (YIDD with YVDD), which evade detection by direct sequencing become discernible by PCR-RFLP. However, in our study some cases did not yield any result as the viral load in the sample tested remained below the sensitivity threshold of this method. Although mutations in the YMDD motif of HBV, as well as mixed populations between wild type and mutants or between mutants can be detected by PCR-RFLP, two major problems of this method are that it takes approximately 24 hours to completion and also, that in cases with very low viral load the results upon agarose gel electrophoresis are very difficult to interpret. Hence, in some cases the discordant result compare with the other technique were appeared (Table 1) .
These problems can be solved applying realtime PCR using LNA mediated TaqMan probe. The TaqMan Probe functions by hybridizing to the target DNA, the probe is then digested by the 5′ to 3′ exonuclease activity of Taq polymerase during extension releasing a fluorescent signal (Suzuki et al. 2005) . The fluorescent signals attached to that probe are detected. The locked nucleic acids (LNAs) are nucleotide analogues that are conformationally locked in a C3′-endo/ N-type sugar conformation by O2′ to C4′ methylene linkage (Koshkin et al. 1998; Ichikawa et al. 1999; Wang et al. 1999 ) that leads to reduced conformational flexibility (Braasch and Corey 2001) . To increase duplex stability between LNAcontaining oligonucleotides and standard nucleic acids, using the LNA mediated TaqMan probe as an analog of the TaqMan probe is advantageous because it can increase thermal stability (about 3-8°C per modified base in the probe) (Letertre et al. 2003; Kennedy et al. 2005) . Therefore, the oligonucleotide of the LNA mediated TaqMan probes are shorter than the general TaqMan probe at the same melting temperatures (Tm). Based on this property, it was used for SNP (Choleva et al. 2001; Johnson et al. 2004 ) and point mutation detection. In this study, three LNA mediated TaqMan probes specific for YMDD, YIDD and YVDD and tracking three different fluorescent signals, FAM, Cy5 and Hex, respectively, were designed all of which can detect most genotypes of HBV (genotypes A, B, C, D, E, and G) except genotypes H and F. Moreover, when using this method for sample detection, the results correlated with those obtained by direct sequencing. Also, even in samples with a viral load below the threshold of detection by direct sequencing (approximately 10 3 copies/μ l) and PCR-RFLP, the variants could be detected by real-time PCR. Hence, real-time PCR using LNA mediated TaqMan probe seemed to be an appropriate method for mutation detection at the YMDD motif of HBV. However, in some cases that the mixed population of the wild type and mutant were detected by real-time PCR whereas the others technique were not detected. For example, the mixed population between M and I detected by real-time PCR while the PCR-RFLP and direct sequencing could detect only the wild type M in Sample NO. CU13. Because the viral load of the mutant population (I) was very low which had the high Ct value in the real-time PCR method (data not shown), so the only wild type was detected in these techniques. To ensure that the mixed population was existed in this sample the cloned analysis should be performed. Unfortunately, the quantities of clinical samples were not enough to achieve. Any differences in results observed among these techniques depend on a set of PCR primers that were required for the amplification of viral DNA. Since the primers for each technique were different, they may bind differently to each sample, especially if there was variation in the sequence at the site where the primers bind. This could account for some of the differences in results predominantly seen when serum samples contained low amounts of viral DNA.
In conclusion, both PCR-RFLP and real-time PCR using LNA-mediated TaqMan probe are efficient methods to detect mutations at the YMDD motif of HBV in serum samples. However, realtime PCR is less time-consuming, and more sensitive for the detection of mixed populations than PCR-RFLP. The method described here could also be applied for detecting further resistant mutants emerging in response to other oral antiviral therapies, although specific primer design and PCR optimization may be necessary for each assay.
